CRANBURY, N.J.--(BUSINESS WIRE)--CURE® Magazine, the nation’s leading digital and print media enterprise focused on patients with cancer, cancer centers and advocacy groups, is accepting nominations for the 2017 MPN Heroes® Program honoring individuals who have made a difference in the field of rare blood cancers known as myeloproliferative neoplasms (MPNs) by going above and beyond the standard of care, demonstrating leadership within the MPN community and/or a commitment to individual patients.
In making the announcement Michael J. Hennessy, Jr., president of Michael J. Hennessy Associates, parent company of CURE® Magazine said, “We are excited to be accepting nominations for this year’s MPN Heroes Awards. We are delighted to recognize another group of exceptional individuals who each and every day make a difference within the MPN community.”
Nominations for the MPN Heroes are accepted from the community at large. Nominations are reviewed by a panel of judges who are responsible for picking the finalists and winners in two categories: Commitment to the Individual and Commitment to the Broader MPN Community. For more information, to submit a nomination and learn more about this year’s MPN Heroes Recognition Program Rules and judges, visit www.mpnheroes.com.
This year’s MPN Heroes will be honored at the 5th Annual MPN Heroes Recognition Event on December 8, 2017, in Atlanta, GA.
Supporting the recognition of MPN Heroes and the MPN community is an ongoing effort of Incyte Corporation. Individuals or entities supported through funding or directed by Incyte are not eligible for consideration or recognition.
About CURE®:
CURE Media Group is the leading resource for cancer updates, research and education. It combines a full suite of media products, including its industry leading website, CUREtoday.com; innovative video programs, such as CURE Connections®; a series of widely attended live events; and CURE® magazine, which reaches over 1 million readers. CURE Media Group is part of the Cranbury, New Jersey- based Michael J. Hennessy Associates, Inc., family of businesses, which includes the acclaimed OncLive® (http://www.onclive.com) platform of resources for the practicing oncologist. For more information, visit curetoday.com or mjhassoc.com.
About Incyte:
Incyte Corporation is a Wilmington, Del. -based biopharmaceutical company focused on the discovery, development and commercialization of proprietary therapeutics. For additional information on Incyte, please visit the company’s website at http://www.incyte.com.
